About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Prostate Cancer Clinical Trials | 7,504 Studies Recruiting

Clinical TrialsProstate Cancer

Prostate Cancer Clinical Trials

Browse 7,504 clinical trials for prostate cancer. Find studies that match your criteria and connect with research centers.

Find trials near:

New York Los Angeles Chicago Houston Phoenix Philadelphia

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4No phase

Who can join

Healthy volunteers too

Showing 6501-6520 of 7,504 trials

UnknownDaily Target Guided Radiation Therapy Using the Calypso 4D Localization System in Patients Who Have Had a Prostatectomy for Prostate CancerThis study will evaluate the daily use of a unique daily organ tracking system on target localization in patients treated with radiation therapy after radical prostatectomy for…NCT01624623·Tacoma, Washington Active not recruitingDose-dEscalated MR-Guided Radiotherapy for Localized Prostate CancerDESTINATION 2 is a multi-centre randomised trial treating intermediate risk localised prostate cancer with 2 fraction Stereotactic Body Radiotherapy (SBRT).NCT07674225·Toronto, Ontario UnknownStudy of Serum and Urinary Biomarkers and Radiation Cystitis in Patients Treated With Radiotherapy for Localized Prostate CancerProstate cancer represents the 1st diagnosed cancer in men, with 50400 new cases and 8100 deaths in 2018.NCT05246774·Saint-Mandé

Related Searches

prostate carcinomatrials

Data from ClinicalTrials.govTerms

CompletedSafety and Pharmacokinetics of ODM-209The purpose of this first-in-human study is to evaluate safety and tolerability of ODM-209 and find the dose of ODM-209.NCT03878823·Copenhagen and 3 others

CompletedAbemaciclib (LY2835219) in Men With Heavily Treated Metastatic Castration-Resistant Prostate CancerThe study will evaluate how safe and effective abemaciclib is when given to participants whose metastatic prostate cancer progresses after they had received several previous…NCT04408924·Salt Lake City, Utah and 13 others

TerminatedMRI Guided Prostate Cancer Focal Laser AblationThe study is a prospective, single-arm, non-randomized, unblinded trial to determine the safety and efficacy of MRI guided focal laser ablation of localized low and intermediate…NCT03634579·Atlanta, Georgia

CompletedSBRT in 4 Fractions for Prostate CancerThis is a prospective multicentric phase-I-II pilot feasibility study.NCT03873090

CompletedEfficacy and Safety of VasoClip® vs. WeckClip® for Robotic Urologic SurgeryThis prospective, randomized, Phase III trial evaluates the efficacy and safety of VasoClip®, a novel polymer surgical clip with a Z-groove and an elastic notch, designed to…NCT07413120·Incheon

TerminatedSafety Study of MGD009 in B7-H3-expressing TumorsThe purpose of this study is to evaluate the safety of MGD009 when given to patients with B7-H3-expressing tumors.NCT02628535·Los Angeles, California and 19 others

CompletedNerve-Sparing Radical Prostatectomy With or Without Nerve Grafting Followed by Standard Therapy for Erectile Dysfunction in Treating Patients With Localized Prostate CancerRATIONALE: Nerve-sparing radical prostatectomy with nerve grafting followed by standard therapies for erectile dysfunction may be effective in helping patients with prostate…NCT00080808·Houston, Texas

Not yet recruitingRE-irradiation for Isolated FOCal Recurrence of Prostate Cancer With Ultrahypofracted SBRTProstate cancer (PCa) is one of the most frequently diagnosed malignancies in men worldwide, with the highest prevalence observed in developed countries.NCT07810660

CompletedZD4054 (Zibotentan) in Pain-free or Mildly Symptomatic Patients With Prostate Cancer and Bone Metastases Who Have Rising Serum Prostate Specific Antigen (PSA)This study is being carried out to see if ZD4054 (Zibotentan) is effective in treating prostate cancer and spread of cancer to the bone, and if so, how it compares with placebo…NCT00090363·Tucson, Arizona and 59 others

Active not recruitingA Study to Learn More About How Safe Darolutamide is Under Real-world Conditions in Participants With Metastatic Hormone-Sensitive Prostate CancerThis is an observational study in which only data are collected from participants receiving their usual treatment.NCT06010914·Multiple Locations

CompletedPrimary Prostatic Lymphoma on a 66 Year-old Male in Mexico.A 66-year-old male known case of diabetes and hypertension presented to the urology clinic with a 2-month history of lower urinary tract symptoms (LUTS), particularly poor flow…NCT07134504·Colonia del Valle, D.F

Completed'OLAP' (OLAparib Regulatory Post-marketing Surveillance)The objectives of this study are to assess safety and effectiveness of Lynparza tablet (olaparib, hereinafter "the study drug") in a real world setting in patients who are…NCT04553926·Ansan and 17 others

UnknownTesetaxel in Chemotherapy-naive Patients With Progressive, Castration-resistant Prostate CancerGiven the activity of docetaxel in patients with progressive, metastatic castration-resistant prostate cancer, this study is being undertaken to evaluate the activity of…NCT01296243·Ann Arbor, Michigan and 3 others

TerminatedGa-68-PSMA-11 in Men With Prostate CancerThe purpose of this study is to provide access to Ga-68-PSMA-11 PET for evaluation of male veterans with newly diagnosed or biochemically recurrent prostate cancer.NCT05744115·Columbia, Missouri

CompletedOGX-011 and Docetaxel in Treating Patients With Metastatic or Locally Recurrent Solid TumorsRATIONALE: OGX-011 may kill tumor cells by blocking some of the proteins that may cause tumor cells to grow.NCT00471432

CompletedStudy of Talazoparib, a PARP Inhibitor, in Patients With Advanced or Recurrent Solid TumorsThis is a single-arm, open-label study to assess the safety, pharmacokinetics, pharmacodynamics, and preliminary efficacy of talazoparib in patients with advanced tumors with…NCT01286987·Scottsdale, Arizona and 14 others

Active not recruitingAn Observational Study to Learn More About Treatment Patterns and Factors Determining the Choice of Treatment in Canadian Men With Metastatic Hormone Sensitive Prostate Cancer in Routine Medical CareThis is an observational study in which only data are collected from adult Canadian men with metastatic hormone sensitive prostate cancer (mHSPC) are studied.NCT06874114·Toronto, Ontario

PreviousPage 326 of 376Next